This activity is jointly provided by The Consortium of Multiple Sclerosis Centers (CMSC) and Catamount Medical Education.
This activity is supported by independent educational grants from
Biogen and Bristol Myers Squibb.
Target Audience
MS specialists, general neurologists, nursing professionals, pharmacists, PAs, and patient advocates in the care of people living with multiple sclerosis (MS).
Faculty
Robert K. Shin, MD, FANA, FAAN
Professor, Department of Neurology
MedStar Georgetown University Hospital
Washington, DC
Accreditation
In support of improving patient care, this activity has been planned and implemented by The Consortium of Multiple Sclerosis Centers (CMSC) and Catamount Medical Education. CMSC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the health care team.
Credits available for Physicians, Pharmacists and Nursing Professionals
MedPointsTM in Multiple Sclerosis Initial Therapy
Learning Objectives
At the conclusion of this activity, participants should be better able to:
- Discuss evidence-based treatment decision-making related to early treatment initiation and its impact on patient outcomes
- Review key efficacy and safety data for available disease-modifying therapies (DMTs) when making early treatment decisions
- Utilize treatment- and patient-specific considerations, along with patient preferences, in making initial and subsequent therapy decisions
Release date: March 3, 2023
Expiration date: March 3, 2024
The estimated time to complete the activity is 30 minutes.
MedPointsTM in Multiple Sclerosis Patient Perspectives
Learning Objectives
At the conclusion of this activity, participants should be better able to:
- Utilize treatment- and patient-specific considerations, along with patient preferences, in making initial and subsequent therapy decisions
Release date: March 3, 2023
Expiration date: March 3, 2024
The estimated time to complete the activity is 30 minutes.
MedPointsTM in Multiple Sclerosis DMTs and the Immune System
Learning Objectives
At the conclusion of this activity, participants should be better able to:
- Examine the mechanisms of action of disease-modifying therapies (DMTs) and the clinical implications of their effects on the immune system
Release date: March 30, 2023
Expiration date: March 30, 2024
The estimated time to complete the activity is 30 minutes.
MedPointsTM in Multiple Sclerosis DMTs and COVID-19
Learning Objectives
At the conclusion of this activity, participants should be better able to:
- Review evidence and recommendations related to DMTs and vaccine response, including to COVID-19 vaccines, in people with MS
Release date: March 30, 2023
Expiration date: March 30, 2024
The estimated time to complete the activity is 30 minutes.